A emerging medical domain concerns hybrid chains. Such synthetic entities merge sections derived from multiple protein families, facilitating the development of unique pharmacological functions. The method presents the https://chimerapeptides487928.widblog.com/98525673/chimera-peptides-a-novel-therapeutic-frontier